601 results on '"Yoshioka, H."'
Search Results
2. 014 Sex as a variable in the composition of skin residing T cells
3. 443 Frequency of IL-22 expression on CD4+ T cells in psoriatic lesion may negatively correlate with the disease prognosis
4. 072 Down-regulation of semaphorin 4A in keratinocytes can reflect the disease-associated features in non-lesional skin of psoriasis
5. 810 Distinct transcriptional profiles in the different phenotypes of neurofibroma from the same neurofibromatosis 1 subject
6. 051 The development and functional activities of skin resident memory T cells depends more on fatty-acid binding protein 5 than on fatty-acid binding protein 4
7. MICRO-SOLIDIFICATION PROCESS IN MULTI-COMPONENT SYSTEM
8. 330P A real-world multi-center prospective observational study of atezolizumab (Atezo) + bevacizumab (Bev) + carboplatin (CBDCA) + paclitaxel (PTX) (ABCP) in patients (pts) with advanced EGFR-mutated (EGFRm) NSCLC after EGFR-TKIs failure
9. Optimisation of Radiation Therapy in Bladder Preservation Therapy for Patients With Clinical Stage T2N0M0 Bladder Cancer
10. “Smart” base isolation systems: Theory and experiments
11. EP08.02-133 Sequential Afatinib to Osimertinib in EGFR-mutant NSCLC: A Prospective Observational Study, Gio-Tag Japan Interim Report
12. Final overall survival analysis from the phase III J-ALEX study of alectinib versus crizotinib in ALK inhibitor-naïve Japanese patients with ALK-positive non-small-cell lung cancer
13. MA02.05 A Phase I Study of Afatinib in Combination With Osimertinib in Patients After Failure of Prior Osimertinib
14. Development of a New Spalling Test Method for Bottom Blowing Tuyeres for BOFS
15. Polyethylene glycol-based linkers as hydrophilicity reservoir for antibody-drug conjugates
16. A multicenter cohort study of osimertinib compared with afatinib as first-line treatment for EGFR-mutated non-small-cell lung cancer from practical dataset: CJLSG1903
17. P84.02 A Phase II Trial of Alectinib-Refractory Non-Small-Cell Lung Cancer with EML4-ALK Fusion Genes; Okayama Lung Cancer Study Group 1405
18. P21.01 Phase I Study of Carboplatin/Nab-Paclitaxel and Concurrent TRT in Elderly Patients with Unresectable Locally Advanced NSCLC
19. P76.79 Osimertinib in Poor PS Patients with T790M-Positive Advanced NSCLC after Progression of EGFR TKI Treatments (NEJ032B)
20. Tempered Stable Ornstein–Uhlenbeck Model for River Discharge Time Series with Its Application to Dissolved Silicon Load Analysis
21. OA03.05 Phase III Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer
22. Novel six-axis robot kinematic model with axis-to-axis crosstalk
23. Reliable method for controlling tunnel convergence based on analytical results and monitoring results in squeezing rocks
24. Molecular mechanisms of the radical burst in plant immunity.
25. 405P Promising efficacy as combination therapy of DFP-14323, protease inhibitor, with EGFR-TKI in patients with metastatic NSCLC harboring EGFR mutation
26. LBA55 WJOG @Be study: A phase II study of atezolizumab (atez) with bevacizumab (bev) for non-squamous (sq) non-small cell lung cancer (NSCLC) with high PD-L1 expression
27. 005 Respiratory activity in psoriatic circulating T cells predicts the efficacy of apremilast
28. A Randomized Phase II Study of Maintenance Bevacizumab, Pemetrexed, or Bevacizumab+Pemetrexed in Advanced Nonsquamous Non-Small Cell Lung Cancer (Kyoto Thoracic Oncology Research Group 1101)
29. On a non-standard two-species stochastic competing system and a related degenerate parabolic equation
30. Interventional Procedures
31. The Oxidative Burst System in Plants: A Strategic Signal Transduction System for Triggering Active Defense and for Parasites to Overcome
32. Higher Order Parallel DNS of Incompressible Turbulence Using Compressible Navier-Stokes Equations
33. Characterization of ZrO2 thin films prepared from zirconium alkoxide by sol–gel or CVD methods
34. Final overall survival results of WJTOG3405, a randomized phase III trial comparing gefitinib versus cisplatin with docetaxel as the first-line treatment for patients with stage IIIB/IV or postoperative recurrent EGFR mutation-positive non-small-cell lung cancer
35. Study of searching on efficacy of immune checkpoint inhibitor for the non-small cell lung cancer using FDG-PET/CT and thallium SPECT
36. Updated survival outcomes of the phase II study of low starting dose of afatinib as first-line treatment in patients with EGFR mutation-positive non-small cell lung cancer (KTORG1402)
37. Compact and on-demand 3D-printed optical device based on silicone optical technology (SOT) for on-site measurement: Application to flow injection analysis
38. EP1.01-45 Cisplatin Plus Gemcitabine Therapy Followed by Maintenance Gemcitabine for Advanced Squamous Cell Lung Cancer (KTORG1302)
39. P1.01-04 A Phase II Trial of Weekly Nab-Paclitaxel in the Salvage Setting for Advanced Non-Small Cell Lung Cancer: Results of NICE Salvage Study
40. MA13.06 Ph3 Study of Maintenance Therapy with S-1 vs BSC After Induction Therapy with Carboplatin + S-1 for Advanced Squamous Cell Lung Cancer (WJOG7512L)
41. 305 A rare case of borderline brenner tumor
42. 017 Tc2 induction of IL-10-producing plasmablasts during contact hypersensitivity
43. 003 Aging alteration of skin T cells is different from that of blood T cells
44. Sweat retention anhidrosis associated with tubular aggregate myopathy
45. CD 8 resident memory T cells with interleukin 17A‐producing potential are accumulated in disease‐naïve nonlesional sites of psoriasis possibly in correlation with disease duration
46. EP-1588 The preliminary result of combination of chemoradiotherapy and arterial infusion for bladder cancer
47. CD103 negative memory T cells may play important roles in making regulatory T‐cell‐enriched environments in skin tumours
48. Fluctuations of Josephson Currents in Mesoscopic Systems
49. Recent studies of chemical properties of amorphous alloys
50. Skin resident memory T‐cell population is not constructed effectively in systemic sclerosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.